Isabel Filges Selected Research

Arts syndrome

3/2021

Co-therapy with S-adenosylmethionine and nicotinamide riboside improves t-cell survival and function in Arts Syndrome (PRPS1 deficiency).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabel Filges Research Topics

Disease

3	Intellectual Disability (Idiocy) 01/2020 - 04/2012
1	Rare Diseases (Rare Disease) 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Trisomy (Trisomies) 10/2021
1	Arts syndrome 03/2021
1	Congenital Abnormalities (Deformity) 12/2020
1	Microcephaly 01/2020
1	Otocephaly 01/2020
1	Hydrops Fetalis (Fetal Edema) 01/2017
1	Autistic Disorder (Autism) 01/2016
1	46,XY Gonadal Dysgenesis (Swyer Syndrome) 10/2011
1	Schinzel-Giedion syndrome 02/2011
1	Neoplasms (Cancer) 05/2005

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2011
1	dichlorobis(azomycin)platinum IIIBA 10/2021
1	nicotinamide-beta-ribosideIBA 03/2021
1	S-Adenosylmethionine (Ademetionine)IBA 03/2021
1	KinesinsIBA 12/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2017
1	ubiquinone Q3IBA 01/2016
1	Codon (Codons)IBA 04/2012
1	Carrier Proteins (Binding Protein)IBA 02/2011

Therapy/Procedure

2	Therapeutics 01/2022 - 03/2021
1	Prenatal Care (Care, Prenatal) 01/2022
1	Chemoprevention 05/2005